Vanguard Group
KITE

Vanguard Group’s Kite Pharma, Inc. KITE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,094,002
Closed -$736M 4144
2017
Q3
$736M Buy
4,094,002
+95,733
+2% +$17.2M 0.03% 574
2017
Q2
$415M Buy
3,998,269
+336,722
+9% +$34.9M 0.02% 784
2017
Q1
$287M Buy
3,661,547
+507,289
+16% +$39.8M 0.01% 989
2016
Q4
$141M Buy
3,154,258
+120,122
+4% +$5.39M 0.01% 1398
2016
Q3
$169M Buy
3,034,136
+98,730
+3% +$5.52M 0.01% 1220
2016
Q2
$147M Buy
2,935,406
+173,879
+6% +$8.69M 0.01% 1242
2016
Q1
$127M Buy
2,761,527
+132,185
+5% +$6.07M 0.01% 1315
2015
Q4
$162M Buy
2,629,342
+506,104
+24% +$31.2M 0.01% 1138
2015
Q3
$118M Buy
2,123,238
+492,684
+30% +$27.4M 0.01% 1319
2015
Q2
$99.4M Buy
1,630,554
+110,285
+7% +$6.72M 0.01% 1531
2015
Q1
$87.7M Buy
1,520,269
+793,906
+109% +$45.8M 0.01% 1590
2014
Q4
$41.9M Buy
726,363
+223,543
+44% +$12.9M ﹤0.01% 1924
2014
Q3
$14.3M Buy
+502,820
New +$14.3M ﹤0.01% 2341